サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678769

避妊器具の世界市場（2025年～2033年）

Global Contraceptive Devices Market - 2025-2033

出版日
ページ情報
英文 163 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
避妊器具の世界市場（2025年～2033年）
出版日: 2025年03月11日
発行: DataM Intelligence
ページ情報: 英文 163 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の避妊器具の市場規模は、2024年に109億8,000万米ドルに達し、2033年には193億7,000万米ドルに達する見込みで、2025年～2033年の予測期間中にCAGR6.6％で成長すると予測されています。

避妊器具は、精子が卵子に到達するのを妨害するか、あるいは妊娠の可能性を低くするために体内のホルモンまたは物理的環境を変化させることによって、妊娠を防止するように設計された物理的製品です。これらの器具にはさまざまな形があり、男女ともに使用することができます。ピルや注射のようなホルモン法と並んで、最も一般的な避妊法のひとつです。避妊器具は、家族計画、リプロダクティブ・ヘルス（性と生殖に関する健康）、人口管理における重要なソリューションを提供します。

避妊器具の需要は、人口統計学的、社会的、経済的、ヘルスケア関連の複合的要因によって、世界中で着実に増加しています。このような需要の増加は、主に、より良い家族計画、より効果的な生殖管理、性の健康に対する意識の高まり、斬新な製品の発売を望む声に影響されています。例えば、2024年9月、ConTIPI MedicalはEVERSANAと提携し、ProVateデバイスの米国での商業的発売をサポートしました。

市場力学：

促進要因と抑制要因

意識の高まりと政府の取り組み

意識の高まりと政府の取り組みが避妊器具市場の成長を大きく後押ししており、予測期間中も市場を牽引するとみられます。世界各国の政府は、家族計画が経済発展、ヘルスケアコスト、男女平等に直接的な影響を与えることを認識し、公衆衛生の重要な側面として優先しています。多くの国々が、幅広い人々がよりアクセスしやすく、手頃な価格で利用できるようにする国家家族計画プログラムを立ち上げています。

例えば、インドの国家家族計画プログラムは、同国の避妊具配布努力の要となっています。インドは人口増加率の削減を目指しており、政府の補助金や啓発キャンペーンを通じて、何百万人もの人々に近代的な避妊法を紹介してきました。2020年、インドではIUDやインプラントなどの長時間作用型可逆的避妊薬（LARC）の使用が増加しました。

啓発キャンペーンは、政府主導であれNGO主導であれ、避妊法に関する重要な情報を、特に十分なサービスを受けていない農村部の幅広い人々にもたらしました。こうした取り組みは、避妊の利点を強調し、避妊に関する神話や誤った情報と闘うための正確な情報を提供するものです。一般の人々、特に若者や女性を教育することで、政府や組織は避妊の使用に対する障壁を取り除き、より高い需要につなげています。

例えば米国などでは、家族計画連盟（Planned Parenthood）のような団体が、避妊法に関する意識を高めるための教育プログラムを実施しています。こうしたプログラムは、個人にリプロダクティブ・ヘルスの選択肢に関する情報を提供することで、避妊法の普及を促進することを目的としています。2021年には、米国で240万人以上が家族計画連盟が提供する避妊サービスを利用しており、啓発プログラムの有効性を示しています。

副作用と健康への懸念

避妊器具は妊娠を予防し生殖をコントロールするという点で大きな利点を提供しますが、副作用と健康上の懸念は依然として市場成長を妨げる重要な要因です。こうした懸念はしばしば特定の方法の使用をためらわせ、最初の使用後に使用を中止させることさえあり、全体的な採用と市場拡大を制限しています。

人気の高い避妊器具、特にIUD（子宮内避妊器具）、インプラント、膣リングのようなホルモン系の選択肢の多くは、ホルモンを体内に放出します。これらの方法は妊娠を防ぐのに非常に効果的ですが、しばしば様々な副作用を伴うため、継続的な使用を躊躇させます。また、特に無菌環境や訓練を受けたヘルスケア専門家によって行われない場合、挿入時に感染や子宮穿孔のリスクが伴います。

不妊の問題やがんリスクの増加など、ホルモン避妊法が健康に与える長期的な影響を懸念する人もいます。インプラントやIUDのようなホルモン器具の使用は、生殖能力を低下させたり、使用中止後の正常な生殖能力への復帰を遅らせたりするのではないかという懸念があります。しかし、こうした懸念は誤った情報や古い研究に基づいていることが多くあります。

目次

第1章 市場イントロダクションと範囲

  • レポートの目的
  • 調査のカバー範囲と定義
  • 調査の対象範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • スニペット：製品タイプ別
  • スニペット：技術別
  • スニペット：ジェンダー別
  • スニペット：流通チャネル別
  • スニペット：地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 意識の向上と政府の取り組み
      • 避妊器具の進歩の高まり
    • 抑制要因
      • 副作用と健康上の懸念
      • 避妊器具の高いコスト
    • 機会
      • 政府の取り組み
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名企業
    • 最大の販売ブランドを持つ確立されたリーダー
    • 確立された製品を持つ市場リーダー
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学
  • キーオピニオンリーダー

第5章 避妊器具市場：製品タイプ

  • コンドーム
  • ペッサリーおよび子宮頸管キャップ
  • 避妊用スポンジ
  • 膣リング
  • 子宮内避妊器具（IUD）
  • 皮下インプラント

第6章 避妊器具市場：技術別

  • ホルモン避妊薬
  • バリア避妊具

第7章 避妊器具市場：ジェンダー別

  • 男性
  • 女性

第8章 避妊器具市場：流通チャネル別

  • 院内薬局
  • 小売薬局
  • オンラインチャンネル
  • その他

第9章 避妊器具市場：地域別の市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • CooperSurgical, Inc.
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Pregna International Limited
  • Reckitt Benckiser group
  • Veru Inc.
  • Bayer AG
  • Abbvie Inc.
  • EUROGINE, S.L.
  • Mona Lisa N.V.
  • Prosan International BV
  • OCON Medical Ltd.

第12章 前提条件と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証とバリデーション

第13章 付録

目次
Product Code: MD9240

The global contraceptive devices market reached US$ 10.98 billion in 2024 and is expected to reach US$ 19.37 billion by 2033, growing at a CAGR of 6.6% during the forecast period of 2025-2033.

Contraceptive devices are physical products designed to prevent pregnancy by either obstructing sperm from reaching an egg or altering the body's hormonal or physical environment to make pregnancy less likely. These devices come in various forms and can be used by both men and women. They are one of the most common methods of birth control, alongside hormonal methods like pills or injections. Contraceptive devices provide a critical solution in family planning, reproductive health, and population control.

The demand for contraceptive devices has been steadily increasing worldwide, driven by a combination of demographic, social, economic, and healthcare-related factors. This growing demand is primarily influenced by the desire for better family planning, more effective control over reproduction, increasing awareness of sexual health, and novel product launches. For instance, in September 2024, ConTIPI Medical partnered with EVERSANA to support the US commercial launch of the ProVate device.

Market Dynamics: Drivers & Restraints

Rising Awareness and Government Initiatives

The rising awareness and government initiatives are significantly driving the growth of the contraceptive devices market and are expected to drive the market over the forecast period. Governments worldwide are prioritizing family planning as a key aspect of public health, recognizing that it has a direct impact on economic development, healthcare costs, and gender equality. Many countries have launched national family planning programs that make contraceptive devices more accessible and affordable to a broad population.

For instance, the National Family Planning Program in India has been a cornerstone of the country's contraceptive distribution efforts. India aims to reduce its population growth rate, and through government subsidies and awareness campaigns, millions of people have been introduced to modern contraceptive methods. In 2020, India saw an increase in the use of long-acting reversible contraceptives (LARCs) such as IUDs and implants.

Awareness campaigns, whether spearheaded by governments or NGOs, have brought crucial information about contraceptive methods to a wide range of people, particularly in underserved and rural areas. These initiatives emphasize the benefits of contraceptive devices and provide accurate information to combat myths and misinformation about contraception. By educating the public, particularly young people and women, governments and organizations are removing barriers to contraceptive use, leading to higher demand.

For instance, in countries like the United States, organizations like Planned Parenthood run education programs to raise awareness about contraceptive methods. These programs aim to equip individuals with information on their reproductive health options, thus increasing the adoption of contraceptive methods. In 2021, over 2.4 million people in the U.S. used contraceptive services provided by Planned Parenthood, illustrating the effectiveness of awareness programs.

Side Effects and Health Concerns

While contraceptive devices offer significant benefits in terms of preventing pregnancy and controlling reproduction, side effects and health concerns remain key factors that can hamper market growth. These concerns often lead to hesitancy in using certain methods and can even result in discontinuation after initial use, limiting their overall adoption and market expansion.

Many popular contraceptive devices, particularly hormonal options like IUDs (intrauterine devices), implants, and vaginal rings, release hormones into the body. While these methods are highly effective in preventing pregnancy, they often come with a range of side effects that deter users from continued use. However, there are associated risks of infection and uterine perforation upon insertion, especially if not performed in a sterile environment or by trained healthcare professionals.

Some individuals are concerned about the long-term impact of hormonal contraceptive methods on their health, including fertility issues or increased cancer risk. There are fears that the use of hormonal devices like implants or IUDs may reduce fertility or delay the return to normal fertility after stopping use. However, these concerns are often based on misinformation or outdated studies.

Segment Analysis

The global contraceptive devices market is segmented based on product type, technology, gender, distribution channel, and region.

Product Type:

The condoms is expected to dominate in the product type segment of contraceptive devices market with the share.

The condoms segment holds a dominant position in the global contraceptive devices market due to several factors, including affordability, ease of use, dual protection against both pregnancy and sexually transmitted infections (STIs), and wide availability. The combination of these factors has made condoms the most widely used form of contraception worldwide.

One of the most significant reasons for the dominance of condoms is that they provide dual protection against both pregnancy and sexually transmitted infections (STIs). Unlike other contraceptive methods, such as IUDs or hormonal contraceptives, condoms are the only method that also helps prevent the transmission of diseases like HIV, chlamydia, and gonorrhea. This makes condoms particularly popular in regions with high rates of STIs.

For instance, according to the World Health Organization, 374 million new STI infections occurred globally among adults aged 15-49 with 1 of the 4 curable STIs: syphilis, chlamydia, gonorrhea, and trichomoniasis. Most of these could be prevented with the correct use of condoms.

Condoms are low-cost compared to other contraceptive methods, which makes them highly accessible to a wide demographic, including low-income populations. Many countries offer free or subsidized condoms through public health initiatives, making them available to even those in remote or underserved areas. The wide availability, coupled with affordability, has made condoms the most used method of contraception globally.

Geographical Analysis

North America is expected to hold a significant position in the contraceptive devices market with the highest market share

North America boasts one of the highest levels of awareness and education about family planning and sexual health globally. Comprehensive sex education programs, particularly in the U.S. and Canada, ensure that individuals have a clear understanding of contraception methods, their benefits, and their side effects. This has led to the widespread acceptance and use of various contraceptive devices.

For instance, according to the Guttmacher Institute, 99% of women aged 15-44 in the U.S. who have had sex have used at least one contraceptive method, with 75% of them using modern methods like IUDs, implants, and condoms. The high level of awareness about birth control options directly drives demand for contraceptive devices.

Governments in North America actively promote family planning and reproductive health through subsidies, awareness campaigns, and public health programs. These initiatives play a critical role in ensuring that contraceptive devices are accessible and affordable for a broad population. For instance, the United States government supports family planning through federal programs like Title X, which provides funding for family planning clinics.

Asia-Pacific is growing at the fastest pace in the contraceptive devices market

The Asia-Pacific region has the largest population in the world, with over 4.6 billion people, representing about 60% of the global population. This vast population, especially in countries like India and China, creates a substantial demand for family planning solutions and contraceptive methods. As the population continues to grow, governments and individuals are increasingly turning to contraception to control family sizes and improve reproductive health.

For instance, with a population exceeding 1.4 billion people, India is one of the world's most populous countries, and the demand for contraceptives is increasing as families seek to manage the birth rate. According to the National Family Health Survey (NFHS), over 50% of married women in India use modern contraceptive methods, with a significant portion opting for IUDs, condoms, and oral contraceptive pills. India's government has actively promoted family planning through programs like Mission Parivar Vikas, aiming to increase contraceptive prevalence.

Governments in the Asia-Pacific region play a critical role in promoting family planning and contraceptive use through policies and financial support. Many countries have established national programs to distribute contraceptive devices, reduce birth rates, and improve maternal health. This government backing has directly contributed to the growing contraceptive market. For instance, India has consistently emphasized family planning in its national policies, and its National Family Planning Program has expanded access to free or subsidized contraceptives across the country. This has led to a rise in the use of IUDs, oral contraceptives, and sterilization methods.

Competitive Landscape

The major global players in the contraceptive devices market include CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group, Veru Inc., Bayer AG, Abbvie Inc., EUROGINE, S.L., Mona Lisa N.V., Prosan International BV, and OCON Medical Ltd., among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global contraceptive devices market report delivers a detailed analysis with 70 key tables, more than 64 visually impactful figures, and 163 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Gender
  • 2.6. Snippet by Distribution Channel
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Awareness and Government Initiatives
      • 3.1.1.2. Rising Advancements in Contraceptive Devices
    • 3.1.2. Restraints
      • 3.1.2.1. Side Effects and Health Concerns
      • 3.1.2.2. High Cost of Contraceptive Devices
    • 3.1.3. Opportunity
      • 3.1.3.1. Government Initiatives
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Contraceptive Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Condoms*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Diaphragms and Cervical Caps
  • 5.4. Sponges
  • 5.5. Vaginal Rings
  • 5.6. Intrauterine Devices (IUDs)
  • 5.7. Sub-dermal Implants

6. Contraceptive Devices Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Hormonal Contraceptives*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Barrier Contraceptives

7. Contraceptive Devices Market, By Gender

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 7.1.2. Market Attractiveness Index, By Gender
  • 7.2. Male*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Female

8. Contraceptive Devices Market, By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Hospital Pharmacies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Retail Pharmacies
  • 8.4. Online Channels
  • 8.5. Others

9. Contraceptive Devices Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. CooperSurgical, Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Pregna International Limited
  • 11.3. Reckitt Benckiser group
  • 11.4. Veru Inc.
  • 11.5. Bayer AG
  • 11.6. Abbvie Inc.
  • 11.7. EUROGINE, S.L.
  • 11.8. Mona Lisa N.V.
  • 11.9. Prosan International BV
  • 11.10. OCON Medical Ltd.

"*" Indicates similar breakdown for other companies

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us